欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FR/V/0420/001
药品名称RISPOVAL 2
活性成分
    • Bovine parainfluenza 3 virus 5.0 log10 TCID50
    • bovine respiratory syncytial virus 5.0 log10 TCID50
剂型Lyophilisate and solvent for suspension for injection
上市许可持有人ZOETIS
参考成员国 - 产品名称France (FR)
RISPOVAL 2 / BRSV + PI3 LYOPHILISATE AND SUSPENSION
互认成员国 - 产品名称
    • Germany (DE)
    • Belgium (BE)
      Rispoval 2 / BRSV + Pi3
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
      Rispoval 2 / BRSV + Pi3
    • Spain (ES)
    • Portugal (PT)
    • Latvia (LV)
      Rispoval 2 / BRSV + Pi3 liofilizāts un šķīdinātājs suspensijas injekcijām pagatavošanai liellopiem
    • Lithuania (LT)
    • Estonia (EE)
      Rispoval 2 / BRSV + Pi3
    • Hungary (HU)
    • Czechia (CZ)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2020/10/21
最近更新日期2024/09/24
药物ATC编码
    • QI02AD07 bovine respiratory syncytial virus + bovine parainfluenza virus
申请类型
  • TypeLevel1:food
  • TypeLevel2:Immunological
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase